Dehydroepiandrosterone sulphate is increased and dehydroepiandrosterone-response to corticotrophin-releasing hormone is decreased in the hyperthyroid state compared with the euthyroid state

Clinical Endocrinology

Volumn 55, Issue 6, 2001, Pages 797-803

  Yamakita, Noriyoshi ^a   Murai, Toshihiro ^a   Kokubo, Yoshiaki ^a   Hayashi, Makoto ^a   Akai, Akifumi ^a   Yasuda, Keigo ^b  

^a Matsunami General Hospital   (Japan)

^b GIFU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR; HYDROCORTISONE; PRASTERONE; PRASTERONE SULFATE; THIAMAZOLE;

ADULT; AREA UNDER THE CURVE; ARTICLE; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CORTICOTROPIN BLOOD LEVEL; DISEASE COURSE; DOSE RESPONSE; EUTHYROIDISM; FEMALE; GRAVES DISEASE; HORMONAL REGULATION; HORMONE BLOOD LEVEL; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYPERTHYROIDISM; MALE; MEASUREMENT; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROVOCATION TEST; TREATMENT OUTCOME;

ADRENOCORTICOTROPIC HORMONE; ADULT; ANTITHYROID AGENTS; AREA UNDER CURVE; CORTICOTROPIN-RELEASING HORMONE; DEHYDROEPIANDROSTERONE; DEHYDROEPIANDROSTERONE SULFATE; FEMALE; HUMANS; HYDROCORTISONE; HYPERTHYROIDISM; MALE; METHIMAZOLE; MIDDLE AGED; THYROTROPIN; THYROXINE; TRIIODOTHYRONINE;

EID: 0035657619     PISSN: 03000664     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2265.2001.01420.x     Document Type: Article

References (36)

1. Value of serum dehydroepiandrosterone sulfate assay in the evaluation of pituitary-adrenal insufficiency after pituitary adenomectomy
2. Hormonal changes and catabolic/anabolic imbalance in chronic heart failure and their importance for cardiac cachexia
3. Arginine-vasopressin and endothelium-associated proteins in thyroid disease
4. Stimulatory effect of adrenocorticotropin on cortisol, aldosterone, and dehydroepiandrosterone secretion in normal humans: Dose-response study
5. Effect of dehydroepiandrosterone sulfate on cellular calcium responsiveness and vascular contractility
6. Plasma dehydroepiandrosterone sulphate in hypothyroid premenopausal women
7. Endogenous androgens and carotid intimal-medial thickness in women
8. Therapeutic effects of dehydroepiandrosterone (DHEA) in diabetic mice
9. Effect of genetic background on the therapeutic effects of dehydroepiandrosterone (DHEA) in diabetes-obesity mutants and in aged normal mice
10. Responses of plasma adrenocortical steroids to low dose ACTH in normal subjects
11. Mechanism of DHEA action
12. The adrenal cortex in thyrotoxicosis
13. Trabecular bone remodeling and bone balance in hyperthyroidism
14. Exogenous hyperthyroidism with osteoporosis
15. Dehydroepiandrosterone sulfate (DS), dehydroepiandrosterone (D) and 'free' dehydroepiandrosterone (FD) in the plasma of patients with thyroid diseases
16. Decreased serum IGF-I and dehydroepiandrosterone sulfate may be risk factors for the development of reduced bone mass in postmenopausal women with endogenous subclinical hyperthyroidism
17. Inhibition of migration and proliferation of vascular smooth muscle cells by dehydroepiandrosterone sulfate
18. Reduction of atherosclerosis by administration of dehydroepiandrosterone. A study in the hypercholesterolemic New Zealand white rabbit with aortic intimal injury
19. Hormone of the adrenal cortex
20. Thyroid hormone and the cardiovascular system
21. Dehydroepiandrosterone metabolism
22. Serum levels of dehydroepiandrosterone sulfate in patients with asymptomatic cortisol producing adrenal adenoma: Comparison with adrenal Cushing's syndrome and non-functioning adrenal tumor
23. The plasma levels of dehydroepiandrosterone sulfate are decreased in patients with chronic heart failure in proportion to the severity
24. Aromatase in bone cell: Association with osteoporosis in postmenopausal women
25. Regulation of human dehydroepiandrosterone metabolism by insulin
26. Suppression of serum dehydroepiandrosterone sulfate levels by insulin: An evaluation of possible mechanisms
27. Acute effects of triiodothyronine on arterial smooth muscle cells
28. Alterations in the kinetics of C-peptide and insulin secretion in hyperthyroidism
29. Effects of ACTH and cytokines on dehydroepiandrosterone sulfotransferase messenger RNA in human adrenal cells
30. The thyroid and the heart
31. 24-Hour secretory pattern of dehydroepiandrosterone and dehydroepiandrosterone sulfate
32. Serum dehydroepiandrosterone, dehydroepiandrosterone sulfate, and pregnenolone sulfate concentrations in patients with hyperthyroidism and hypothyroidism
33. 1,25-Dihydrovitamin D3 enhances the enzymatic activity and expression of the messenger ribonucleic acid for aromatase cytochrome P 450 synergistically with dexamethasone depending on the vitamin D receptor level in cultured human osteoblasts
34. The low-dose (1 μg) adrenocorticotropin stimulation test in the evaluation of patients with suspected central adrenal insufficiency
35. Adhesive recognition sequences
36. Serum dehydroepiandrosterone sulfate concentrations in secondary adrenal insufficiency